Advances in Drug Discovery TechniquesISBN: 978-0-471-97509-0
Hardcover
224 pages
June 1998
![]() |
Sense, Nonsense and Antisense: Different Approaches to Drug Discovery (A. Harvey).
Natural Products for Durg Discovery: An Overview (P. Waterman).
Advanced Screening Technology and Informatics for Natural Products Drug Discovery (D. Hill).
Discovery of Specific Tyrosine Kinase Inhibitors from Microbial and Botanical Sources (G. McMahon, et al.).
Plant Cell Culture: A Vehicle for Drug Discovery (A. Stafford, et al.).
Pharmacy of the Deep -
Marine Organisms as Sources of Anticancer Agents (M. Jaspars).
Drug Discovery by Using Molecular Biology to Reprogramme Microorganisms (I. Hunter).
Small Molecule Drug Screening Based on Surface Plasmon Resonance (S. Kumar & K. Gunnarsson).
An Overview of Combinatorial Chemistry and Its Applications to the Identification of Matric Metalloproteinase Inhibitors (MMPIs) (S. Shuttleworth).
New Methods for Structure-based De Novo Drug Design (B. Waszkowycz).
Current and Future Capabilities in Automated Drug Screening and Development (I. Norrington).
Antisense Oligonucleotide Therapeutics (C. Bennett, et al.).
Index.
Natural Products for Durg Discovery: An Overview (P. Waterman).
Advanced Screening Technology and Informatics for Natural Products Drug Discovery (D. Hill).
Discovery of Specific Tyrosine Kinase Inhibitors from Microbial and Botanical Sources (G. McMahon, et al.).
Plant Cell Culture: A Vehicle for Drug Discovery (A. Stafford, et al.).
Pharmacy of the Deep -
Marine Organisms as Sources of Anticancer Agents (M. Jaspars).
Drug Discovery by Using Molecular Biology to Reprogramme Microorganisms (I. Hunter).
Small Molecule Drug Screening Based on Surface Plasmon Resonance (S. Kumar & K. Gunnarsson).
An Overview of Combinatorial Chemistry and Its Applications to the Identification of Matric Metalloproteinase Inhibitors (MMPIs) (S. Shuttleworth).
New Methods for Structure-based De Novo Drug Design (B. Waszkowycz).
Current and Future Capabilities in Automated Drug Screening and Development (I. Norrington).
Antisense Oligonucleotide Therapeutics (C. Bennett, et al.).
Index.